Endophytic Fungi: A Future Prospect for Breast Cancer Therapeutics and Drug Development

Overview

Journal Heliyon

Specialty Social Sciences

Date 2024 Aug 2

PMID 39091955

Authors

Sherin Varghese

M S Jisha

K C Rajeshkumar

Virendra Gajbhiye

Abdulwahed Fahad Alrefaei

Rajesh Jeewon

Affiliations

Soon will be listed here.

Abstract

Globally, breast cancer is a primary contributor to cancer-related fatalities and illnesses among women. Consequently, there is a pressing need for safe and effective treatments for breast cancer. Bioactive compounds from endophytic fungi that live in symbiosis with medicinal plants have garnered significant interest in pharmaceutical research due to their extensive chemical composition and prospective medicinal attributes. This review underscores the potentiality of fungal endophytes as a promising resource for the development of innovative anticancer agents specifically tailored for breast cancer therapy. The diversity of endophytic fungi residing in medicinal plants, success stories of key endophytic bioactive metabolites tested against breast cancer and the current progress with regards to studies and clinical trials on endophytic fungal metabolites in breast cancer research forms the underlying theme of this article. A thorough compilation of putative anticancer compounds sourced from endophytic fungi that have demonstrated therapeutic potential against breast cancer, spanning the period from 1990 to 2022, has been presented. This review article also outlines the latest trends in endophyte-based drug discovery, including the use of artificial intelligence, machine learning, multi-omics approaches, and high-throughput strategies. The challenges and future prospects associated with fungal endophytes as substitutive sources for developing anticancer drugs targeting breast cancer are also being highlighted.

Citing Articles

Apium graveolens-associated Aspergillus sp.: metabolomic profiling and anti-MRSA potential supported by in silico studies.

Gomaa A, Abou-Zied H, Farhan S, Bedaiwi R, Alanazi M, Glaeser S Microb Cell Fact. 2025; 24(1):57.

PMID: 40057756 PMC: 11889860. DOI: 10.1186/s12934-025-02645-9.

Microbiome Integrity Enhances the Efficacy and Safety of Anticancer Drug.

Mafe A, Busselberg D Biomedicines. 2025; 13(2).

PMID: 40002835 PMC: 11852609. DOI: 10.3390/biomedicines13020422.

Metagenomic analysis and bioactive profiling of kombucha fermentation: antioxidant, antibacterial activities, and molecular docking insights into gastric cancer therapeutics.

Shalini T, Prathiviraj R, Senthilraja P Toxicol Res (Camb). 2024; 13(6):tfae224.

PMID: 39712641 PMC: 11662944. DOI: 10.1093/toxres/tfae224.

References

Patridge E, Gareiss P, Kinch M, Hoyer D . An analysis of FDA-approved drugs: natural products and their derivatives. Drug Discov Today. 2015; 21(2):204-7. DOI: 10.1016/j.drudis.2015.01.009. View

Penel N, Adenis A, Bocci G . Cyclophosphamide-based metronomic chemotherapy: after 10 years of experience, where do we stand and where are we going?. Crit Rev Oncol Hematol. 2011; 82(1):40-50. DOI: 10.1016/j.critrevonc.2011.04.009. View

Rouzier R, Rajan R, Wagner P, Hess K, Gold D, Stec J . Microtubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancer. Proc Natl Acad Sci U S A. 2005; 102(23):8315-20. PMC: 1149405. DOI: 10.1073/pnas.0408974102. View

Ramanakumar A . Need for epidemiological evidence from the developing world to know the cancer-related risk factors. J Cancer Res Ther. 2007; 3(1):29-33. DOI: 10.4103/0973-1482.31968. View

Gonzalez-Menendez V, Perez-Bonilla M, Perez-Victoria I, Martin J, Munoz F, Reyes F . Multicomponent Analysis of the Differential Induction of Secondary Metabolite Profiles in Fungal Endophytes. Molecules. 2016; 21(2). PMC: 6272891. DOI: 10.3390/molecules21020234. View

Anyaogu D, Mortensen U . Heterologous production of fungal secondary metabolites in Aspergilli. Front Microbiol. 2015; 6:77. PMC: 4322707. DOI: 10.3389/fmicb.2015.00077. View

Kassi E, Sourlingas T, Spiliotaki M, Papoutsi Z, Pratsinis H, Aligiannis N . Ursolic acid triggers apoptosis and Bcl-2 downregulation in MCF-7 breast cancer cells. Cancer Invest. 2009; 27(7):723-33. DOI: 10.1080/07357900802672712. View

Shweta S, Zuehlke S, Ramesha B, Priti V, Mohana Kumar P, Ravikanth G . Endophytic fungal strains of Fusarium solani, from Apodytes dimidiata E. Mey. ex Arn (Icacinaceae) produce camptothecin, 10-hydroxycamptothecin and 9-methoxycamptothecin. Phytochemistry. 2009; 71(1):117-22. DOI: 10.1016/j.phytochem.2009.09.030. View

Tiwari P, Bae H . Endophytic Fungi: Key Insights, Emerging Prospects, and Challenges in Natural Product Drug Discovery. Microorganisms. 2022; 10(2). PMC: 8876476. DOI: 10.3390/microorganisms10020360. View

10.

Guruceaga X, Perez-Cuesta U, Abad-Diaz de Cerio A, Gonzalez O, Alonso R, Hernando F . Fumagillin, a Mycotoxin of : Biosynthesis, Biological Activities, Detection, and Applications. Toxins (Basel). 2019; 12(1). PMC: 7020470. DOI: 10.3390/toxins12010007. View

11.

Pommier Y . Topoisomerase I inhibitors: camptothecins and beyond. Nat Rev Cancer. 2006; 6(10):789-802. DOI: 10.1038/nrc1977. View

12.

Kampan N, Madondo M, McNally O, Quinn M, Plebanski M . Paclitaxel and Its Evolving Role in the Management of Ovarian Cancer. Biomed Res Int. 2015; 2015:413076. PMC: 4475536. DOI: 10.1155/2015/413076. View

13.

Uzma F, Mohan C, Hashem A, Konappa N, Rangappa S, Kamath P . Endophytic Fungi-Alternative Sources of Cytotoxic Compounds: A Review. Front Pharmacol. 2018; 9:309. PMC: 5932204. DOI: 10.3389/fphar.2018.00309. View

14.

Koul M, Kumar A, Deshidi R, Sharma V, Singh R, Singh J . Cladosporol A triggers apoptosis sensitivity by ROS-mediated autophagic flux in human breast cancer cells. BMC Cell Biol. 2017; 18(1):26. PMC: 5520384. DOI: 10.1186/s12860-017-0141-0. View

15.

Wagenaar M, Corwin J, Strobel G, Clardy J . Three new cytochalasins produced by an endophytic fungus in the genus Rhinocladiella. J Nat Prod. 2001; 63(12):1692-5. DOI: 10.1021/np0002942. View

16.

El-Hawary S, Sayed A, Mohammed R, Hassan H, Zaki M, Rateb M . Epigenetic Modifiers Induce Bioactive Phenolic Metabolites in the Marine-Derived Fungus . Mar Drugs. 2018; 16(8). PMC: 6117726. DOI: 10.3390/md16080253. View

17.

Strobel G, Daisy B, Castillo U, Harper J . Natural products from endophytic microorganisms. J Nat Prod. 2004; 67(2):257-68. DOI: 10.1021/np030397v. View

18.

Garcia-Oliveira P, Otero P, Pereira A, Chamorro F, Carpena M, Echave J . Status and Challenges of Plant-Anticancer Compounds in Cancer Treatment. Pharmaceuticals (Basel). 2021; 14(2). PMC: 7918405. DOI: 10.3390/ph14020157. View

19.

Newman D, Cragg G . Natural Products as Sources of New Drugs from 1981 to 2014. J Nat Prod. 2016; 79(3):629-61. DOI: 10.1021/acs.jnatprod.5b01055. View

20.

Sledge Jr G, Toi M, Neven P, Sohn J, Inoue K, Pivot X . The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor-Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy-MONARCH 2: A Randomized Clinical Trial. JAMA Oncol. 2019; 6(1):116-124. PMC: 6777264. DOI: 10.1001/jamaoncol.2019.4782. View